Segment Reporting

The Bayer Group lost de facto control over the Covestro Group at the end of the third quarter. As of September 30, therefore, there are four reporting segments: Pharmaceuticals, Consumer Health, Crop Science and Animal Health. As such, total figures for the four Life Science segments will no longer be presented separately.

The following table shows the reconciliation of EBITDA before special items of the above-mentioned segments and the reconciliation to income before income taxes of the Group from continuing operations:

Reconciliation of Segments’ EBITDA Before Special Items to Group Income Before Income Taxes

 

 

Q3 2016

Q3 2017

 

9M 2016

9M 2017

 

 

€ million

€ million

 

€ million

€ million

2016 figures restated

1

For definition see Annual Report 2016, Chapter “Alternative Performance Measures Used by the Bayer Group.”

EBITDA before special items of segments

 

2,236

2,320

 

7,675

7,855

EBITDA before special items of Corporate Functions and Consolidation

 

(118)

(116)

 

(163)

(350)

EBITDA before special items1

 

2,118

2,204

 

7,512

7,505

Depreciation, amortization and impairment losses before special items of segments

 

(595)

(564)

 

(1,855)

(1,623)

Depreciation, amortization and impairment losses before special items of Corporate Functions and Consolidation

 

(1)

(3)

 

(4)

(9)

Depreciation, amortization and impairment losses before special items

 

(596)

(567)

 

(1,859)

(1,632)

EBIT before special items of segments

 

1,641

1,756

 

5,820

6,232

EBIT before special items of Corporate Functions and Consolidation

 

(119)

(119)

 

(167)

(359)

EBIT before special items1

 

1,522

1,637

 

5,653

5,873

Special items of segments

 

(121)

(249)

 

(486)

(592)

Special items of Corporate Functions and Consolidation

 

(4)

0

 

(15)

(3)

Special items1

 

(125)

(249)

 

(501)

(595)

EBIT of segments

 

1,520

1,506

 

5,334

5,640

EBIT of Corporate Functions and Consolidation

 

(123)

(118)

 

(182)

(362)

EBIT1

 

1,397

1,388

 

5,152

5,278

Financial result

 

(233)

(403)

 

(741)

(1,068)

Income before income taxes

 

1,164

985

 

4,411

4,210